CEFTOLOZANE AND TAZOBACTAM

CEFTOLOZANE AND TAZOBACTAM was reported 982 times

CEFTOLOZANE AND TAZOBACTAM is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 TRACHEAL ASPIRATE CULTURE 2 0.4000
1 JEJUNOSTOMY CLOSURE 1 0.3333
2 GLUCOSE TOLERANCE TEST 1 0.1667
3 MINIMUM INHIBITORY CONCENTRATION INCREASED 2 0.1000
4 ENDOCARDITIS PSEUDOMONAL 1 0.0714
5 VENTRICULAR PRE-EXCITATION 2 0.0645
6 MINIMUM INHIBITORY CONCENTRATION 2 0.0606
7 ASTROVIRUS TEST POSITIVE 1 0.0333
8 STENOTROPHOMONAS TEST POSITIVE 4 0.0299
9 FUNGAL DISEASE CARRIER 3 0.0297
10 LARYNGEAL POLYP 1 0.0256
11 JEJUNECTOMY 1 0.0222
12 ALKALOSIS HYPOCHLORAEMIC 3 0.0214
13 BANDAEMIA 3 0.0204
14 PHOSPHORUS METABOLISM DISORDER 1 0.0196
15 VASCULAR ACCESS MALFUNCTION 1 0.0185
16 MICROBIOLOGY TEST ABNORMAL 1 0.0169
17 GRANULOCYTOSIS 3 0.0153
18 PROCALCITONIN ABNORMAL 1 0.0143
19 ANTIMICROBIAL SUSCEPTIBILITY TEST RESISTANT 4 0.0129
20 WITHDRAWAL OF LIFE SUPPORT 1 0.0123
21 PNEUMONIA PSEUDOMONAL 17 0.0111
22 PANCREATIC DUCT STENOSIS 1 0.0110
23 PNEUMONIA NECROTISING 7 0.0108
24 COLON GANGRENE 1 0.0108
25 BENZODIAZEPINE DRUG LEVEL INCREASED 1 0.0105
26 INFECTIVE EXACERBATION OF BRONCHIECTASIS 3 0.0098
27 MEDICAL DEVICE SITE THROMBOSIS 1 0.0097
28 URINE BILIRUBIN INCREASED 1 0.0096
29 INTESTINAL CONGESTION 1 0.0096
30 BRONCHIAL HAEMORRHAGE 3 0.0096
31 INCISION SITE CELLULITIS 1 0.0093
32 ORAL LICHENOID REACTION 1 0.0092
33 INFUSION SITE PHLEBITIS 2 0.0088
34 BURKHOLDERIA TEST POSITIVE 1 0.0081
35 INTENSIVE CARE UNIT ACQUIRED WEAKNESS 3 0.0079
36 HYPOALDOSTERONISM 2 0.0073
37 EXPLORATIVE LAPAROTOMY 1 0.0072
38 PANCREATIC FISTULA 1 0.0065
39 PROCEDURAL PNEUMOTHORAX 1 0.0065
40 ENTEROBACTER PNEUMONIA 1 0.0064
41 CREATININE URINE DECREASED 1 0.0063
42 THORACIC OPERATION 1 0.0061
43 PATHOGEN RESISTANCE 54 0.0059
44 HAEMOGLOBINAEMIA 1 0.0058
45 JEJUNOSTOMY 1 0.0055
46 PRODUCT COMPOUNDING QUALITY ISSUE 2 0.0055
47 ADMINISTRATION RELATED REACTION 1 0.0051
48 CELLULITIS GANGRENOUS 1 0.0051
49 GRAM STAIN POSITIVE 1 0.0049
50 PRODUCT ADMINISTRATION ISSUE 1 0.0048
51 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
52 CLOSTRIDIAL SEPSIS 1 0.0041
53 ACTIVATED PARTIAL THROMBOPLASTIN TIME ABNORMAL 1 0.0040
54 PULMONARY CONTUSION 1 0.0040
55 CYTOMEGALOVIRUS TEST POSITIVE 7 0.0039
56 CRITICAL ILLNESS 3 0.0038
57 OSTEOMYELITIS BACTERIAL 1 0.0036
58 WHITE BLOOD CELL COUNT 1 0.0034
59 GASTROINTESTINAL MUCOSA HYPERAEMIA 1 0.0034
60 BLOOD CREATINE DECREASED 1 0.0033
61 ASPERGILLUS TEST POSITIVE 1 0.0032
62 WOUND INFECTION PSEUDOMONAS 1 0.0032
63 LOW CARDIAC OUTPUT SYNDROME 1 0.0030
64 PNEUMONIA ESCHERICHIA 1 0.0029
65 PNEUMONITIS ASPIRATION 1 0.0029
66 ANASTOMOTIC COMPLICATION 1 0.0029
67 PANCREATIC NECROSIS 1 0.0029
68 LYMPHOMA TRANSFORMATION 1 0.0028
69 ANGIODYSPLASIA 1 0.0027
70 HEMIPARAESTHESIA 1 0.0026
71 FISTULA OF SMALL INTESTINE 1 0.0024
72 NITRITE URINE PRESENT 1 0.0023
73 GASTROENTERITIS NOROVIRUS 3 0.0023
74 CONGESTIVE HEPATOPATHY 1 0.0022
75 ALLERGY TEST POSITIVE 1 0.0022
76 LAPAROTOMY 1 0.0022
77 EXTRAVASATION 9 0.0022
78 COOMBS POSITIVE HAEMOLYTIC ANAEMIA 1 0.0022
79 INTRACRANIAL MASS 2 0.0021
80 PSEUDOMONAS INFECTION 18 0.0021
81 INTESTINAL ANGIOEDEMA 1 0.0021
82 DRAINAGE 1 0.0020
83 PROTEIN-LOSING GASTROENTEROPATHY 1 0.0020
84 CRYSTALLURIA 1 0.0018
85 NOSOCOMIAL INFECTION 4 0.0018
86 LUNG INFECTION PSEUDOMONAL 1 0.0018
87 EJECTION FRACTION 1 0.0017
88 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
89 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
90 FAT NECROSIS 1 0.0016
91 NECROSIS 9 0.0016
92 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
93 RESTING TREMOR 1 0.0015
94 SHORT-BOWEL SYNDROME 1 0.0015
95 INTERCEPTED PRODUCT SELECTION ERROR 2 0.0015
96 KLEBSIELLA TEST POSITIVE 1 0.0015
97 C-REACTIVE PROTEIN DECREASED 1 0.0015
98 PNEUMOCOCCAL SEPSIS 1 0.0015
99 LUNG TRANSPLANT REJECTION 1 0.0015
100 BLOOD LACTATE DEHYDROGENASE ABNORMAL 1 0.0015
101 STENOTROPHOMONAS INFECTION 2 0.0015
102 PULMONARY SEPSIS 2 0.0014
103 PARESIS 3 0.0013
104 HYPERCAPNIA 4 0.0013
105 ALLERGIC COUGH 1 0.0013
106 CYTOMEGALOVIRUS ENTEROCOLITIS 1 0.0013
107 HEPATOCELLULAR INJURY 18 0.0013
108 ENTEROCOCCAL SEPSIS 1 0.0012
109 BRONCHITIS CHRONIC 3 0.0012
110 PSEUDOMONAS TEST POSITIVE 1 0.0012
111 GLOMERULAR FILTRATION RATE INCREASED 1 0.0012
112 IMMUNOSUPPRESSANT DRUG LEVEL INCREASED 4 0.0012
113 SYSTEMIC CANDIDA 3 0.0012
114 PSEUDOMONAL BACTERAEMIA 1 0.0012
115 DRUG RESISTANCE 30 0.0012
116 PSEUDOMONAL SEPSIS 2 0.0011
117 TRANSPLANT REJECTION 9 0.0011
118 MONOPARESIS 2 0.0011
119 ENCEPHALOPATHY 27 0.0011
120 SUSPECTED PRODUCT QUALITY ISSUE 2 0.0011
121 THROMBOCYTOSIS 4 0.0011
122 PNEUMONIA KLEBSIELLA 2 0.0011
123 CYSTIC FIBROSIS 6 0.0011
124 C-REACTIVE PROTEIN 1 0.0011
125 KLEBSIELLA BACTERAEMIA 1 0.0011
126 INTUSSUSCEPTION 1 0.0010
127 RED BLOOD CELLS URINE POSITIVE 1 0.0010
128 BLADDER CATHETERISATION 1 0.0010
129 ANTIBIOTIC THERAPY 1 0.0010
130 CONTINUOUS HAEMODIAFILTRATION 1 0.0010
131 HAEMOPHILUS INFECTION 1 0.0010
132 COLOSTOMY 2 0.0010
133 MUCOSAL DISORDER 1 0.0010
134 MESENTERIC VEIN THROMBOSIS 1 0.0010
135 HYPERNATRAEMIA 5 0.0010
136 RENAL HAEMORRHAGE 2 0.0010
137 BRAIN STEM INFARCTION 1 0.0010
138 RENAL TUBULAR ACIDOSIS 2 0.0009
139 ARRHYTHMIA SUPRAVENTRICULAR 1 0.0009
140 ACINETOBACTER INFECTION 1 0.0009
141 PNEUMOCYSTIS JIROVECII PNEUMONIA 9 0.0009
142 FOCAL DYSCOGNITIVE SEIZURES 1 0.0009
143 T-CELL LYMPHOMA 1 0.0009
144 DERMATITIS EXFOLIATIVE GENERALISED 3 0.0009
145 AGRANULOCYTOSIS 16 0.0009
146 SHOCK HAEMORRHAGIC 7 0.0009
147 RECALLED PRODUCT ADMINISTERED 8 0.0008
148 BILE DUCT STENOSIS 1 0.0008
149 CHRONIC RESPIRATORY FAILURE 1 0.0008
150 BLOOD UREA DECREASED 1 0.0008
151 STATUS EPILEPTICUS 9 0.0008
152 PRODUCT USED FOR UNKNOWN INDICATION 1 0.0008
153 LUNG INFILTRATION 7 0.0008
154 ORGAN FAILURE 3 0.0007
155 BLOOD SODIUM INCREASED 2 0.0007
156 BODY MASS INDEX INCREASED 1 0.0007
157 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 4 0.0007
158 CLONUS 2 0.0007
159 ENDOTRACHEAL INTUBATION 2 0.0007
160 MAST CELL ACTIVATION SYNDROME 1 0.0007
161 ATYPICAL MYCOBACTERIAL INFECTION 1 0.0007
162 TRACHEOSTOMY 1 0.0007
163 NOROVIRUS INFECTION 1 0.0007
164 FOOT AMPUTATION 1 0.0007
165 IRON DEFICIENCY 3 0.0007
166 GENERALISED TONIC-CLONIC SEIZURE 11 0.0007
167 MYOCLONIC EPILEPSY 1 0.0007
168 MARASMUS 1 0.0007
169 GASTROSTOMY 1 0.0006
170 MULTIPLE-DRUG RESISTANCE 2 0.0006
171 RASH MACULO-PAPULAR 14 0.0006
172 HYPERVOLAEMIA 3 0.0006
173 INFLAMMATORY MARKER INCREASED 3 0.0006
174 ENTEROBACTER INFECTION 1 0.0006
175 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 3 0.0006
176 LEUKAEMIA RECURRENT 1 0.0006
177 CLOSTRIDIAL INFECTION 2 0.0006
178 MEDICAL DEVICE REMOVAL 1 0.0006
179 RECALLED PRODUCT 1 0.0006
180 SEPTIC SHOCK 25 0.0006
181 EXTREMITY NECROSIS 1 0.0006
182 MASTECTOMY 1 0.0006
183 DRUG SCREEN NEGATIVE 1 0.0006
184 FACIAL PARESIS 2 0.0006
185 MITRAL VALVE DISEASE 1 0.0006
186 TRANSPLANT DYSFUNCTION 1 0.0006
187 BLOOD HIV RNA INCREASED 1 0.0006
188 WHITE BLOOD CELLS URINE POSITIVE 1 0.0005
189 GUN SHOT WOUND 1 0.0005
190 MECHANICAL VENTILATION 1 0.0005
191 TONGUE OEDEMA 2 0.0005
192 RADIOTHERAPY 1 0.0005
193 PRODUCT USE IN UNAPPROVED INDICATION 128 0.0005
194 HYPERTRIGLYCERIDAEMIA 3 0.0005
195 BICYTOPENIA 1 0.0005
196 GLUCOSE TOLERANCE IMPAIRED 3 0.0005
197 BACTERAEMIA 6 0.0005
198 CELL DEATH 1 0.0005
199 EMPYEMA 1 0.0005
200 DEEP VEIN THROMBOSIS POSTOPERATIVE 1 0.0005
201 NO ADVERSE EVENT 90 0.0005
202 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
203 LEG AMPUTATION 2 0.0005
204 LUNG ABSCESS 1 0.0005
205 PANCYTOPENIA 26 0.0005
206 AMYOTROPHIC LATERAL SCLEROSIS 1 0.0005
207 PRODUCT PREPARATION ISSUE 3 0.0005
208 TERMINAL STATE 3 0.0004
209 BACTERIAL TEST POSITIVE 1 0.0004
210 ILEUS PARALYTIC 2 0.0004
211 PSEUDOMEMBRANOUS COLITIS 1 0.0004
212 URINE ABNORMALITY 2 0.0004
213 LICHENOID KERATOSIS 1 0.0004
214 METHAEMOGLOBINAEMIA 1 0.0004
215 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
216 RENAL FUNCTION TEST ABNORMAL 2 0.0004
217 GASTRITIS EROSIVE 2 0.0004
218 INCORRECT DOSAGE ADMINISTERED 2 0.0004
219 RETROPERITONEAL HAEMORRHAGE 1 0.0004
220 TACHYARRHYTHMIA 1 0.0004
221 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
222 URINARY TRACT INFECTION BACTERIAL 1 0.0004
223 KLEBSIELLA INFECTION 2 0.0004
224 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
225 ACIDOSIS 3 0.0004
226 MUCORMYCOSIS 1 0.0004
227 EXFOLIATIVE RASH 1 0.0004
228 LUNG OPACITY 1 0.0004
229 WHITE BLOOD CELL DISORDER 1 0.0004
230 INCORRECT PRODUCT ADMINISTRATION DURATION 8 0.0004
231 ACUTE RESPIRATORY FAILURE 7 0.0004
232 CHOLECYSTITIS INFECTIVE 1 0.0004
233 PRODUCT USE ISSUE 67 0.0004
234 LYMPHOPENIA 5 0.0004
235 MULTIPLE ORGAN DYSFUNCTION SYNDROME 10 0.0004
236 NEUROLOGICAL SYMPTOM 2 0.0003
237 EOSINOPHILIA 6 0.0003
238 METABOLIC ENCEPHALOPATHY 1 0.0003
239 CENTRAL VENOUS CATHETERISATION 1 0.0003
240 LEUKOCYTOSIS 6 0.0003
241 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
242 GENERALISED OEDEMA 4 0.0003
243 RESPIRATORY RATE DECREASED 1 0.0003
244 C-REACTIVE PROTEIN ABNORMAL 2 0.0003
245 HYPOVENTILATION 1 0.0003
246 ASPERGILLUS INFECTION 2 0.0003
247 DEAFNESS NEUROSENSORY 1 0.0003
248 INABILITY TO AFFORD MEDICATION 3 0.0003
249 POSTOPERATIVE WOUND INFECTION 2 0.0003
250 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
251 EPILEPSY 9 0.0003
252 WOUND COMPLICATION 1 0.0003
253 HYPERBILIRUBINAEMIA 3 0.0003
254 LARGE INTESTINE PERFORATION 2 0.0003
255 POOR QUALITY PRODUCT ADMINISTERED 3 0.0003
256 NECROTISING FASCIITIS 1 0.0003
257 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
258 MONOCYTE COUNT INCREASED 1 0.0003
259 LIVER TRANSPLANT 1 0.0003
260 ASPIRATION 3 0.0003
261 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
262 BACTERIAL INFECTION 5 0.0003
263 NEPHROPATHY TOXIC 3 0.0003
264 PRODUCT STORAGE ISSUE 1 0.0003
265 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 1 0.0003
266 AMNESIA 17 0.0003
267 CHOLESTASIS 5 0.0003
268 SPINAL CORD COMPRESSION 1 0.0003
269 HAEMORRHAGIC STROKE 2 0.0003
270 RESPIRATORY ACIDOSIS 1 0.0003
271 RESPIRATORY FAILURE 18 0.0002
272 DECUBITUS ULCER 2 0.0002
273 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 1 0.0002
274 RED CELL DISTRIBUTION WIDTH INCREASED 1 0.0002
275 BLOOD UREA INCREASED 4 0.0002
276 MUSCLE ATROPHY 3 0.0002
277 ACUTE KIDNEY INJURY 36 0.0002
278 INCORRECT DRUG ADMINISTRATION RATE 1 0.0002
279 ABSCESS LIMB 1 0.0002
280 ANURIA 2 0.0002
281 CLOSTRIDIUM DIFFICILE INFECTION 5 0.0002
282 INCORRECT PRODUCT STORAGE 3 0.0002
283 ONYCHOMYCOSIS 1 0.0002
284 ADVERSE EVENT 21 0.0002
285 ABDOMINAL ABSCESS 1 0.0002
286 SUSPECTED OFF LABEL USE 1 0.0002
287 LEUKOPENIA 11 0.0002
288 INTERCEPTED MEDICATION ERROR 1 0.0002
289 THROMBOCYTOPENIA 24 0.0002
290 KIDNEY TRANSPLANT REJECTION 1 0.0002
291 ENTEROCOCCAL INFECTION 1 0.0002
292 GUILLAIN-BARRE SYNDROME 1 0.0002
293 PRESCRIBED OVERDOSE 4 0.0002
294 RENAL TUBULAR NECROSIS 2 0.0002
295 VENOOCCLUSIVE LIVER DISEASE 1 0.0002
296 ABDOMINAL TENDERNESS 1 0.0002
297 IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME 1 0.0002
298 PROTEIN URINE PRESENT 1 0.0002
299 CELLULITIS 10 0.0002
300 EMPHYSEMA 2 0.0002
301 HYPOKALAEMIA 9 0.0002
302 PRODUCT PREPARATION ERROR 4 0.0002
303 PRODUCT TEMPERATURE EXCURSION ISSUE 1 0.0002
304 PERIPHERAL VASCULAR DISORDER 1 0.0002
305 TREATMENT FAILURE 16 0.0002
306 SKIN NECROSIS 1 0.0002
307 RENAL FAILURE 25 0.0002
308 COMPRESSION FRACTURE 1 0.0002
309 PRODUCT PRESCRIBING ISSUE 4 0.0002
310 VENTRICULAR FIBRILLATION 2 0.0002
311 PRODUCT AVAILABILITY ISSUE 4 0.0002
312 CORONARY ARTERY BYPASS 1 0.0002
313 PRODUCT LABEL CONFUSION 1 0.0002
314 PRODUCT STORAGE ERROR 15 0.0002
315 HYPERKALAEMIA 6 0.0002
316 HYPOVOLAEMIA 1 0.0002
317 SEPSIS 19 0.0002
318 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 1 0.0002
319 MYOCLONUS 2 0.0002
320 CARDIO-RESPIRATORY ARREST 7 0.0002
321 HEPATITIS CHOLESTATIC 1 0.0002
322 PLATELET COUNT ABNORMAL 1 0.0002
323 LARYNGEAL OEDEMA 1 0.0002
324 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
325 INFUSION SITE EXTRAVASATION 1 0.0002
326 PNEUMONIA ASPIRATION 4 0.0002
327 MULTIPLE INJURIES 1 0.0002
328 OFF LABEL USE 139 0.0002
329 METABOLIC ACIDOSIS 5 0.0002
330 SEIZURE 18 0.0002
331 RENAL IMPAIRMENT 13 0.0002
332 REFUSAL OF TREATMENT BY PATIENT 1 0.0002
333 POST-TRAUMATIC STRESS DISORDER 1 0.0001
334 WRONG PRODUCT ADMINISTERED 1 0.0001
335 PRODUCT LABEL ISSUE 1 0.0001
336 DEFAECATION URGENCY 1 0.0001
337 RIGHT VENTRICULAR FAILURE 1 0.0001
338 HYPOXIA 5 0.0001
339 METASTASIS 1 0.0001
340 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
341 GRAFT VERSUS HOST DISEASE 1 0.0001
342 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
343 MELAENA 3 0.0001
344 TRANSAMINASES INCREASED 3 0.0001
345 PEMPHIGOID 1 0.0001
346 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
347 HAEMODYNAMIC INSTABILITY 1 0.0001
348 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
349 HAEMOLYSIS 1 0.0001
350 LYMPHOMA 2 0.0001
351 ACUTE MYELOID LEUKAEMIA 2 0.0001
352 GASTROINTESTINAL INFLAMMATION 1 0.0001
353 MULTIPLE ALLERGIES 1 0.0001
354 BLOOD DISORDER 1 0.0001
355 CONFUSIONAL STATE 20 0.0001
356 CEREBRAL INFARCTION 3 0.0001
357 VENTRICULAR TACHYCARDIA 2 0.0001
358 DRUG LEVEL INCREASED 2 0.0001
359 EMBOLISM 1 0.0001
360 EOSINOPHIL COUNT INCREASED 1 0.0001
361 GASTROINTESTINAL HAEMORRHAGE 10 0.0001
362 HAEMODIALYSIS 1 0.0001
363 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
364 PYELONEPHRITIS 1 0.0001
365 NEUROTOXICITY 2 0.0001
366 INCORRECT DOSE ADMINISTERED 26 0.0001
367 TUMOUR LYSIS SYNDROME 1 0.0001
368 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 1 0.0001
369 PURPURA 1 0.0001
370 DRUG ERUPTION 2 0.0001
371 HAEMOLYTIC ANAEMIA 1 0.0001
372 OSTEOMYELITIS 2 0.0001
373 C-REACTIVE PROTEIN INCREASED 4 0.0001
374 HYPERGLYCAEMIA 4 0.0001
375 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
376 PNEUMONIA BACTERIAL 1 0.0001
377 PRODUCT DISTRIBUTION ISSUE 1 0.0001
378 PERSONALITY CHANGE 1 0.0001
379 HAEMOPTYSIS 3 0.0001
380 ERYTHEMA MULTIFORME 1 0.0001
381 LEUKAEMIA 1 0.0001
382 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
383 BLOOD CREATINE PHOSPHOKINASE INCREASED 3 0.0001
384 DRUG PRESCRIBING ERROR 2 0.0001
385 ATELECTASIS 1 0.0001
386 THROMBOTIC MICROANGIOPATHY 1 0.0001
387 HOSPICE CARE 1 0.0001
388 HAEMATOCRIT DECREASED 2 0.0001
389 HEPATIC FAILURE 3 0.0001
390 TOXIC SKIN ERUPTION 1 0.0001
391 CONTRAINDICATED PRODUCT ADMINISTERED 3 0.0001
392 BODY TEMPERATURE INCREASED 2 0.0001
393 NEUTROPHIL COUNT INCREASED 1 0.0001
394 EAR DISCOMFORT 1 0.0001
395 OVERDOSE 21 0.0001
396 PERITONITIS 2 0.0001
397 TRANSFUSION 1 0.0001
398 DEATH 81 0.0001
399 BLOOD CREATININE INCREASED 6 0.0001
400 PRODUCT DISPENSING ERROR 2 0.0001
401 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
402 EXPIRED PRODUCT ADMINISTERED 3 0.0001
403 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
404 FUNGAL INFECTION 3 0.0001
405 NERVE INJURY 1 0.0001
406 HAEMATURIA 3 0.0001
407 MICTURITION URGENCY 1 0.0001
408 ELECTROLYTE IMBALANCE 1 0.0001
409 SPINAL PAIN 1 0.0001
410 ACCIDENT 1 0.0001
411 MUSCLE RIGIDITY 1 0.0001
412 ACCIDENTAL OVERDOSE 3 0.0001
413 DRUG INTERACTION 13 0.0001
414 GLOMERULAR FILTRATION RATE DECREASED 1 0.0001
415 PNEUMONIA 26 0.0001
416 DERMATITIS ALLERGIC 1 0.0001
417 GASTRIC CANCER 2 0.0001
418 PLATELET COUNT INCREASED 1 0.0001
419 PULMONARY CONGESTION 1 0.0001
420 SOPOR 1 0.0001
421 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
422 GINGIVAL BLEEDING 1 0.0001
423 ACUTE HEPATIC FAILURE 1 0.0001
424 ERYTHEMA 15 0.0001
425 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
426 HYPOMAGNESAEMIA 1 0.0001
427 WOUND 2 0.0001
428 DISSEMINATED INTRAVASCULAR COAGULATION 1 0.0001
429 SINUS TACHYCARDIA 1 0.0001
430 BRONCHOSPASM 1 0.0001
431 RED BLOOD CELL COUNT DECREASED 2 0.0001
432 CARDIOGENIC SHOCK 1 0.0001
433 PARAESTHESIA ORAL 1 0.0001
434 COMPLICATION ASSOCIATED WITH DEVICE 1 0.0001
435 LIVER FUNCTION TEST ABNORMAL 2 0.0001
436 FLUID OVERLOAD 1 0.0001
437 ANAEMIA 13 0.0001
438 ANGIOEDEMA 3 0.0001
439 PRODUCT QUALITY ISSUE 9 0.0001
440 NEUTROPENIA 9 0.0001
441 CONDITION AGGRAVATED 20 0.0001
442 INSURANCE ISSUE 1 0.0001
443 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
444 DEVICE RELATED INFECTION 1 0.0001
445 PNEUMOTHORAX 1 0.0001
446 RESPIRATORY TRACT CONGESTION 1 0.0001
447 PREMATURE DELIVERY 1 0.0001
448 ABSCESS 1 0.0001
449 BLOOD POTASSIUM INCREASED 1 0.0001
450 LUNG DISORDER 3 0.0001
451 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
452 CYTOMEGALOVIRUS INFECTION 1 0.0001
453 COAGULOPATHY 1 0.0001
454 FACE OEDEMA 1 0.0001
455 CIRCULATORY COLLAPSE 1 0.0001
456 SCAR 1 0.0001
457 DELIRIUM 2 0.0001
458 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
459 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
460 LYMPHOCYTE COUNT DECREASED 1 0.0001
461 ISCHAEMIC STROKE 1 0.0001
462 CEREBRAL HAEMORRHAGE 2 0.0001
463 GOUT 1 0.0001
464 WHITE BLOOD CELL COUNT DECREASED 6 0.0001
465 END STAGE RENAL DISEASE 1 0.0001
466 UNDERDOSE 4 0.0001
467 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
468 DYSARTHRIA 2 0.0001
469 BLOOD SODIUM DECREASED 1 0.0001
470 HYPOCALCAEMIA 1 0.0001
471 DYSPHAGIA 5 0.0001
472 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
473 PYREXIA 18 0.0001
474 DYSTONIA 1 0.0001
475 ATRIAL FIBRILLATION 5 0.0001
476 SURGERY 3 0.0001
477 DEPRESSED LEVEL OF CONSCIOUSNESS 2 0.0001
478 ACTIVITIES OF DAILY LIVING IMPAIRED 1 0.0001
479 BLOOD PRESSURE ABNORMAL 1 0.0001
480 ILL-DEFINED DISORDER 3 0.0000
481 PLEURAL EFFUSION 3 0.0000
482 BONE MARROW FAILURE 1 0.0000
483 INJURY ASSOCIATED WITH DEVICE 1 0.0000
484 RIB FRACTURE 1 0.0000
485 CARDIAC ARREST 4 0.0000
486 DERMATITIS 1 0.0000
487 HALLUCINATION, VISUAL 1 0.0000
488 LIVER FUNCTION TEST INCREASED 1 0.0000
489 PRURITUS GENERALISED 1 0.0000
490 LIVER DISORDER 2 0.0000
491 TACHYCARDIA 4 0.0000
492 STEVENS-JOHNSON SYNDROME 1 0.0000
493 HEPATOTOXICITY 1 0.0000
494 RASH PAPULAR 1 0.0000
495 THERAPY NON-RESPONDER 2 0.0000
496 PANCREATITIS ACUTE 1 0.0000
497 CHROMATURIA 1 0.0000
498 HEPATIC ENZYME INCREASED 3 0.0000
499 SHOCK 1 0.0000
500 MUSCLE TWITCHING 1 0.0000
501 RENAL DISORDER 2 0.0000
502 COGNITIVE DISORDER 2 0.0000
503 PRODUCT PRESCRIBING ERROR 1 0.0000
504 RASH ERYTHEMATOUS 2 0.0000
505 INFECTION 6 0.0000
506 HYPOGLYCAEMIA 2 0.0000
507 LIVER INJURY 1 0.0000
508 HYPOTENSION 8 0.0000
509 CHRONIC KIDNEY DISEASE 3 0.0000
510 CARDIOVASCULAR DISORDER 1 0.0000
511 RASH GENERALISED 1 0.0000
512 HAEMATOMA 1 0.0000
513 DIPLOPIA 1 0.0000
514 RESPIRATORY TRACT INFECTION 1 0.0000
515 HAEMORRHAGE 4 0.0000
516 DEAFNESS 1 0.0000
517 BRADYCARDIA 2 0.0000
518 PLATELET COUNT DECREASED 4 0.0000
519 CARDIAC FAILURE 3 0.0000
520 JAUNDICE 1 0.0000
521 BLOOD BILIRUBIN INCREASED 1 0.0000
522 PNEUMONITIS 1 0.0000
523 RESPIRATORY ARREST 1 0.0000
524 HAEMATOCHEZIA 2 0.0000
525 ANAPHYLACTIC REACTION 2 0.0000
526 PROCEDURAL PAIN 1 0.0000
527 NECK PAIN 2 0.0000
528 TARDIVE DYSKINESIA 1 0.0000
529 PRODUCT DOSE OMISSION IN ERROR 1 0.0000
530 ANGINA PECTORIS 1 0.0000
531 HERPES ZOSTER 2 0.0000
532 PANCREATIC CARCINOMA 1 0.0000
533 BONE PAIN 2 0.0000
534 ASCITES 1 0.0000
535 ACUTE MYOCARDIAL INFARCTION 1 0.0000
536 GASTROINTESTINAL DISORDER 3 0.0000
537 RESPIRATORY DISORDER 1 0.0000
538 DRUG INEFFECTIVE 44 0.0000
539 BLOOD POTASSIUM DECREASED 1 0.0000
540 PREMATURE BABY 1 0.0000
541 DRUG ADMINISTRATION ERROR 1 0.0000
542 RASH 14 0.0000
543 NERVOUS SYSTEM DISORDER 1 0.0000
544 SWOLLEN TONGUE 1 0.0000
545 DRUG-INDUCED LIVER INJURY 1 0.0000
546 CYSTITIS 1 0.0000
547 LACTIC ACIDOSIS 1 0.0000
548 PRODUCT DOSE OMISSION 2 0.0000
549 STAPHYLOCOCCAL INFECTION 1 0.0000
550 LIP SWELLING 1 0.0000
551 TYPE 2 DIABETES MELLITUS 1 0.0000
552 FLUSHING 3 0.0000
553 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
554 NEOPLASM PROGRESSION 1 0.0000
555 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
556 MOBILITY DECREASED 2 0.0000
557 MYELOSUPPRESSION 1 0.0000
558 DRUG EFFECT INCOMPLETE 1 0.0000
559 DYSURIA 1 0.0000
560 HYPERSENSITIVITY 5 0.0000
561 HEPATIC FUNCTION ABNORMAL 1 0.0000
562 INTESTINAL OBSTRUCTION 1 0.0000
563 DISEASE PROGRESSION 3 0.0000
564 DISORIENTATION 1 0.0000
565 COUGH 7 0.0000
566 CARDIAC FAILURE CONGESTIVE 2 0.0000
567 DYSKINESIA 1 0.0000
568 BLINDNESS 1 0.0000
569 LUNG NEOPLASM MALIGNANT 1 0.0000
570 RHABDOMYOLYSIS 1 0.0000
571 POLLAKIURIA 1 0.0000
572 ROAD TRAFFIC ACCIDENT 1 0.0000
573 HYPERTENSION 5 0.0000
574 OSTEOARTHRITIS 1 0.0000
575 URINARY TRACT INFECTION 4 0.0000
576 HYPOACUSIS 1 0.0000
577 MENTAL DISORDER 1 0.0000
578 PULMONARY OEDEMA 1 0.0000
579 THERAPEUTIC RESPONSE UNEXPECTED 1 0.0000
580 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
581 CARDIAC DISORDER 2 0.0000
582 SWELLING 2 0.0000
583 ARRHYTHMIA 1 0.0000
584 DISEASE RECURRENCE 1 0.0000
585 COMA 1 0.0000
586 PRODUCTIVE COUGH 1 0.0000
587 INTERSTITIAL LUNG DISEASE 1 0.0000
588 HEART RATE INCREASED 2 0.0000
589 FLUID RETENTION 1 0.0000
590 HOSPITALISATION 3 0.0000
591 THERAPY CESSATION 1 0.0000
592 HAEMOGLOBIN DECREASED 2 0.0000
593 ECZEMA 1 0.0000
594 DIARRHOEA 12 0.0000
595 DRUG EFFECT DECREASED 1 0.0000
596 RASH PRURITIC 1 0.0000
597 TREMOR 3 0.0000
598 WEIGHT DECREASED 5 0.0000
599 URTICARIA 3 0.0000
600 BLISTER 1 0.0000
601 DYSPNOEA 10 0.0000
602 RHEUMATOID ARTHRITIS 2 0.0000
603 DYSPHONIA 1 0.0000
604 VERTIGO 1 0.0000
605 HYPERHIDROSIS 2 0.0000
606 FEBRILE NEUTROPENIA 1 0.0000
607 BLOOD PRESSURE DECREASED 1 0.0000
608 NEOPLASM MALIGNANT 1 0.0000
609 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 3 0.0000
610 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
611 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 1 0.0000
612 CONSTIPATION 3 0.0000
613 AGITATION 1 0.0000
614 PRODUCT DOSE OMISSION ISSUE 4 0.0000
615 HYPOAESTHESIA 2 0.0000
616 PRURITUS 5 0.0000
617 THROMBOSIS 1 0.0000
618 DRY MOUTH 1 0.0000
619 FOETAL EXPOSURE DURING PREGNANCY 1 0.0000
620 SKIN EXFOLIATION 1 0.0000
621 CEREBROVASCULAR ACCIDENT 2 0.0000
622 INTENTIONAL PRODUCT MISUSE 1 0.0000
623 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
624 COVID-19 2 0.0000
625 INSOMNIA 3 0.0000
626 MATERNAL EXPOSURE DURING PREGNANCY 1 0.0000
627 DEVICE ISSUE 1 0.0000
628 OROPHARYNGEAL PAIN 1 0.0000
629 CHEST PAIN 2 0.0000
630 ASTHENIA 4 0.0000
631 PAIN IN EXTREMITY 3 0.0000
632 SYNCOPE 1 0.0000
633 SOMNOLENCE 2 0.0000
634 SINUSITIS 1 0.0000
635 ILLNESS 1 0.0000
636 ASTHMA 1 0.0000
637 ABDOMINAL PAIN 2 0.0000
638 PALPITATIONS 1 0.0000
639 CHILLS 1 0.0000
640 LOSS OF CONSCIOUSNESS 1 0.0000
641 PSORIASIS 1 0.0000
642 DEHYDRATION 1 0.0000
643 VISION BLURRED 1 0.0000
644 ANXIETY 2 0.0000
645 BLOOD PRESSURE INCREASED 1 0.0000
646 PARAESTHESIA 1 0.0000
647 NAUSEA 5 0.0000
648 DRUG DOSE OMISSION 1 0.0000
649 MYOCARDIAL INFARCTION 1 0.0000
650 BLOOD GLUCOSE INCREASED 1 0.0000
651 HEADACHE 3 0.0000
652 MALAISE 2 0.0000
653 DECREASED APPETITE 1 0.0000
654 BACK PAIN 1 0.0000
655 VOMITING 2 0.0000
656 DIZZINESS 2 0.0000
657 PAIN 2 0.0000
658 FATIGUE 2 0.0000
659 ARTHRALGIA 1 0.0000